The VentureThe Venture

24. Uncovering untreated heart disease with AI and big data: A conversation with egnite’s Joel Portice and Edwards Lifesciences’ Don Bobo

View descriptionShare

Cardiovascular disease remains the number one killer in every developed country, but only one in ten US patients with severe heart ailments received treatment in 2022. Egnite, a healthcare start-up, has ambitious plans to dramatically improve treatment of heart disease by harnessing the power of AI and big data to identify patients who fell through the cracks after being diagnosed. Egnite was spun out from Edwards Lifesciences, a California-based medical technology company, in early 2021. Egnite’s digital platform, CardioCare, steadily gained acceptance among clinicians, physicians, and hospitals, as the industry rapidly adopted new technology during the pandemic. Don Bobo, corporate vice president at Edwards, and Joel Portice, president and CEO of egnite, sat down with McKinsey’s Andrew Roth to discuss the CardioCare platform, the relationship between egnite and Edwards, and the lifesaving capabilities of AI and big data.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. The Venture

    28 clip(s)

The Venture

The Venture is an original podcast hosted by serial business builders from McKinsey. In each episode 
Social links
Follow podcast
Recent clips
Browse 28 clip(s)